2018
DOI: 10.1021/acsnano.7b07782
|View full text |Cite
|
Sign up to set email alerts
|

Protein Profiling and Sizing of Extracellular Vesicles from Colorectal Cancer Patients via Flow Cytometry

Abstract: Extracellular vesicles (EVs) have stimulated considerable scientific and clinical interest, yet protein profiling and sizing of individual EVs remains challenging due to their small particle size, low abundance of proteins, and overall heterogeneity. Building upon a laboratory-built high-sensitivity flow cytometer (HSFCM), we report here a rapid approach for quantitative multiparameter analysis of single EVs down to 40 nm with an analysis rate up to 10 000 particles per minute. Statistically robust particle si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

12
353
3
1

Year Published

2018
2018
2022
2022

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 375 publications
(396 citation statements)
references
References 45 publications
(93 reference statements)
12
353
3
1
Order By: Relevance
“…The Yan laboratory employed high‐sensitivity flow cytometry (HSFCM), which allows detection of single EVs (down to 40 nm size), to compare and characterize protein profiles of EVs isolated from normal colorectal cells and colorectal cancer cells, as well as plasma EVs from colorectal cancer patients . HSFCM identified 85–90% of particles isolated from cultured cells as EVs, while only 70% of particles isolated from platelet‐free patient plasma corresponded to vesicles (probably due to large number of contaminating lipoprotein particles in plasma).…”
Section: Emerging Approaches To Study Ev Heterogeneitymentioning
confidence: 99%
“…The Yan laboratory employed high‐sensitivity flow cytometry (HSFCM), which allows detection of single EVs (down to 40 nm size), to compare and characterize protein profiles of EVs isolated from normal colorectal cells and colorectal cancer cells, as well as plasma EVs from colorectal cancer patients . HSFCM identified 85–90% of particles isolated from cultured cells as EVs, while only 70% of particles isolated from platelet‐free patient plasma corresponded to vesicles (probably due to large number of contaminating lipoprotein particles in plasma).…”
Section: Emerging Approaches To Study Ev Heterogeneitymentioning
confidence: 99%
“…To determine if this human EVmarking reagent could also identify intact EVs we incubated our EV fraction with commercial Alexa Fluorconjugated anti-CD63 (BD Biosciences San Jose, CA; Cat# 561983). This method has been used in the past in FACS analysis of human EVs 43,44,45,46 . About a third of the total events between 100 and 300 nm were anti-CD63 positive and these positive events disappeared with Triton-X 100 treatment, indicating that this anti-CD63 reagent can also be used to bind C. elegans EVs (FIG 4D).…”
Section: Canonical Human Ev Transmembrane Proteins Can Be Used To Idementioning
confidence: 99%
“…[9] Similarly,i tc ould be used to study the heterogeneous EVs.H owever,t he sizes of EVs fall well below the detection limit of conventional flow cytometers,m aking it impossible to do single-EV analysis without significant instrumentation development. [10] Herein, we report the first single-EV flow cytometry analysis (FCA) in conventional flow cytometers enabled by target-initiated engineering (TIE) of DNAnanostructures on individual EVs. This technique employs ac onformation-switchable DNA probe to bind to the EV surface marker,w hich triggers the engineering of aD NA nanostructure by hybridization chain reaction (HCR).…”
mentioning
confidence: 99%